GCI PUBLIC LECTURE SERIES

Learn how the Rosalind & Morris Goodman Cancer Institute at McGill University is translating research into practice: From COVID vaccine to cancer vaccine.

The keynote speaker at this fall's public lecture is Avak Kahvejian, who earned his PhD and BSc in Biochemistry from McGill University. A general partner at Flagship Pioneering, Avak will discuss his experience inventing and launching new therapeutic platforms. Avak's remarks will serve as a kick-off for a panel discussion between four GCI scientists about transforming mRNA research into treatments and approaches that can tackle cancer's greatest challenges. The panel will be moderated by Prof. Joe Schwarz.

Speakers:

Avak Kahvejian, PhD - General Partner, Flagship

Thomas Duchaine, PhD - Associate Director, Rosalind and Morris Goodman Cancer Institute, Professor, Department of Biochemistry, McGill University

Nahum Sonenberg, PhD - Professor, Gilman Cheney Chair in Biochemistry, Department of Biochemistry, McGill University

Jerry Pelletier, PhD - Professor, Department of Biochemistry, McGill University

Morag Park, PhD - Director, Rosalind and Morris Goodman Cancer Institute

Moderator

Joe Schwarcz, PhD - Director, Office for Science and Society, McGill University

More information